Mandatory Site of Service Policy

 

The Mandatory Site of Service policy is part of the Provider-Administered Drug Review Program. The primary objective of Mandatory Site of Service is to guide the administration of select drug infusions to the most economic and clinically appropriate place of treatment:
 

  • Patients receiving ongoing medical specialty drug infusions in an outpatient facility are required to transition the administration of their infusions to a home setting.
  • The patient must have home infusion benefits.
     
  • The patient and the provider must agree to transition care to the alternate setting.
     
  • The physician must approve the use of the alternative place of treatment as clinically appropriate for the patient's infusion.
     
  • All drugs included require precertification through Magellan Rx.
     
  • When required, the home infusion provider will obtain all necessary nursing precertifications as specified by the patient's benefits.
     

Review the policy below for full details.

Policy # Policy Title Print View
PH-90001 Mandatory Site of Service Management Policy